Find uplifting stories about heroes, innovations, and solutions
8 results for "vcu"
A Virginia Commonwealth University student studying bioinformatics just earned one of America's top honors for undergraduate scientists. Rohit Paradkar is using computer science to crack cancer treatment challenges.
After VCU pulled off the biggest first-round comeback in March Madness history, their coach stopped a press conference to thank the unpaid student reporters who never missed a game. His heartfelt shoutout reminded everyone what dedication really looks like.
New genetic analysis at Virginia Commonwealth University has revealed the ancestral origins and physical characteristics of 53 people—including nine children—whose bodies were stolen from African American burial grounds in the 1800s. The breakthrough brings researchers closer to potentially connecting descendants with their ancestors and ensuring proper memorial and burial.
After decades of slow progress, ALS researchers at VCU Health say they're more optimistic about finding a cure than at any point in history. The Richmond team is combining new FDA-approved treatments with cutting-edge research to extend lives and find solutions.
Retired firefighter Greg Leitz faced aggressive prostate cancer alone until a single phone call to VCU Massey Cancer Center's chaplain changed everything. His story reveals why emotional support matters just as much as medical treatment.
Victoria Nguyen graduated high school at 16, landed a coveted L'Oréal internship, and now works to connect other students to similar opportunities. Her journey from backup college choice to innovation ambassador shows how determination turns setbacks into launching pads.
Virginia Commonwealth University is turning cutting-edge research into real treatments through nearly 700 active clinical trials that give patients access to tomorrow's cures today. The academic health system has seen research funding soar 86% since 2018, now topping $500 million annually.
Researchers at Virginia Commonwealth University have developed G2.2, a sugar-based molecule that targets dormant cancer stem cells responsible for relapse. After a decade of work, the breakthrough could prevent cancer from returning in patients who thought they were cured.